Section I
241 – 250 of 4726
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
CITED1 as a marker of favourable outcome in anti-endocrine treated, estrogen-receptor positive, lymph-node negative breast cancer.
(
- Contribution to journal › Article
-
Mark
International Opinions on Grading of Urothelial Carcinoma : A Survey Among European Association of Urology and International Society of Urological Pathology Members
(
- Contribution to journal › Article
-
Mark
Syndecan-4 is a maestro of gastric cancer cell invasion and communication that underscores poor survival
(
- Contribution to journal › Article
-
Mark
AI-based quantification of whole-body tumour burden on somatostatin receptor PET/CT
(
- Contribution to journal › Article
-
Mark
The complexity of kidney disease and diagnosing it - Cystatin C, selective glomerular hypofiltration syndromes and proteome regulation
(
- Contribution to journal › Scientific review
-
Mark
Predictors of survival in advanced oral cancers after salvage surgery with free tissue flap reconstruction
(
- Contribution to journal › Article
-
Mark
Sex and gender differences in treatment intention, quality of life and performance status in the first 100 patients with periampullary cancer enrolled in the CHAMP study
(
- Contribution to journal › Article
-
Mark
Lung adenocarcinoma promotion by air pollutants
(
- Contribution to journal › Article
-
Mark
Molecular characteristics of breast tumors in patients screened for germline predisposition from a population-based observational study
(
- Contribution to journal › Article
-
Mark
Molecular characteristics of lung adenocarcinoma with respect to patient age at diagnosis
(
- Contribution to journal › Article